Infectious Disease Training in Clinical Investigation

临床研究中的传染病培训

• 批准号: 7694026
• 负责人: JAMES R JOHNSON
• 金额: $ 24.75万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-01 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7694026
• 关键词: Clinical Trials; Communicable Diseases; Training

DESCRIPTION (provided by applicant): The principal objective of the T32 program "Infectious Disease Training in Clinical Investigation" is to provide mentored research training that will prepare physician investigators for successful and productive academic careers in Infectious Diseases. The rationale for this program is that this field continues to witness enormous growth and new challenges due to emerging and re-emerging infections, both within the U.S. and globally, for which a new generation of well-trained clinical investigators is needed. To accomplish this goal, an interdisciplinary faculty from the University of Minnesota Medical School (and its Departments of Medicine, Pediatrics, and Microbiology), School of Public Health, College of Pharmacy, College of Dentistry, and College of Veterinary Medicine, as well as the Minnesota Department of Health, has been engaged in this training program. These faculty trainers have expertise in one or more of eight core topic areas relevant to emerging and re-emerging Infections: 1) HIV/AIDS, 2) Invasive Bacterial Infections, 3) Antimicrobial Resistance, 4) Immunodeficiency/Vaccines, 5) International and Immigrant Health, 6) Bioterrorism, 7) Foodborne Infections, and 8) Zoonoses. The program is designed for physicians who have completed an internal medicine or pediatrics residency program, plus at least one year of clinical training in adult or pediatric Infectious Diseases. It will support two years of focused, closely mentored research training in clinical and/or epidemiological research, as well as completion of the requirements for a Master of Public Health in Epidemiology or Master of Science in Clinical Research degree. The program will accept approximately two new trainees annually, giving a total of approximately four trainees in the program at any time. RELEVANCE (See instructions): The relevance of this training program lies in the increasing threat to public health posed by emerging and re-emerging infections, as exemplified by community-associated methicillin-resistant Staphylococcus aureus, the HIV/AIDS epidemic, extensively-drug-resistant tuberculosis, E. coli 0157:H7 outbreaks, and pandemic and avian influenza. This has created a need for additional expert clinical researchers who can discover the causes of, and find remedies for these growing threats.

描述（由申请人提供）：T32计划“临床调查中的传染病培训”的主要目标是提供指导的研究培训，该培训将为医师研究人员做好准备，以使医师的研究人员为成功和富有成效的传染病学术职业做好准备。该计划的理由是，由于在美国和全球范围内，由于新一代训练有素的临床研究人员需要，该领域继续见证了由于出现和重新出现的感染而引起的巨大增长和新的挑战。为了实现这一目标，明尼苏达大学医学院（及其医学，儿科和微生物学系），公共卫生学院，药学学院，牙科学院和兽医学院以及明尼苏达州卫生部以及明尼苏达州卫生部的一名跨学科教师。这些教师培训师在与出现和重新出现感染有关的八个核心主题领域中的一个或多个方面具有专业知识：1）HIV/AIDS，2）侵入性细菌感染，3）3）抗微生物抗性，4）免疫缺陷/疫苗，5）国际和移民健康，6）Bioterrant health，6）Bioterroriss and Zoone and Zoone and Zone and Z）。该计划是为完成了内科或儿科住院医师计划的医师而设计的，以及至少在成人或小儿传染病中进行一年的临床培训。它将支持两年的临床和/或流行病学研究的重点，密切指导的研究培训，以及完成流行病学公共卫生硕士或临床研究学位科学硕士的要求。该计划每年将接受大约两名新学员，并随时在该计划中大约有四名学员。 RELEVANCE (See instructions): The relevance of this training program lies in the increasing threat to public health posed by emerging and re-emerging infections, as exemplified by community-associated methicillin-resistant Staphylococcus aureus, the HIV/AIDS epidemic, extensively-drug-resistant tuberculosis, E. coli 0157:H7 outbreaks, and pandemic and avian流感。这使得可以发现可以发现原因的其他专家临床研究人员，并为这些日益增长的威胁找到补救措施。